Loretta Tioiela is the founder of Next Sequence, a venture capital firm at the forefront of one of the most exciting fields in science and technology: the convergence of artificial intelligence and synthetic biology.
With a rich background in deep tech, holding strategic leadership positions at global giants like Huawei and Samsung, and working as Chief Product Officer at cloud innovator Scaleway, Loretta possesses a unique and powerful perspective.
⭐ Sponsored by Podcast10x - Podcasting agency for VCs - https://podcast10x.com
Next Sequence website - https://www.thenextsequence.vc/
Loretta Tioiela on LinkedIn - https://www.linkedin.com/in/lorettatioiela/
🎙️ Hosted by Prashant Choubey
Follow Prashant on X - https://x.com/ChoubeySahab
Follow Prashant on LinkedIn - https://www.linkedin.com/in/choubeysahab
In this episode, we talk about:
The Dawn of "TechBio" and Programmable Life
The Convergence of AI and Biotech
Redefining Health, Aging, and Disease
Rewiring the Brain and a New Look at Psychedelics
The Future of Computing and Data
The Importance of Open Collaboration In BioTechnology
& lots more
Timestamps:
(00:00) Introduction
(02:40) Defining tech bio and its significance
(03:42) Next Sequence Ventures' investment thesis
(06:11) Convergence of AI, quantum computing, and biotechnology
(09:23) Programmable humans and potential applications
(13:16) Current stage of longevity research and potential for extending human lifespan
(16:07) Exploration of psychedelics and their potential applications
(22:19) OpenSynthBio and the importance of open-source collaboration in biotechnology
(28:18) Portfolio companies and investment strategy
(36:18) Challenges and perspectives as a woman in tech and venture capital
(43:26) Potential breakthroughs in synthetic biology and tech bio for the next few decades
(45:49) Rapid-fire round of questions about investing and the accelerator program
For sponsorship or guest appearance requests, write to prashantchoubey3@gmail.com
Subscribe to VC10X on Youtube, Spotify, Apple Podcasts.